AI Just Mapped 2,812 Viruses to Outrun the Next Pandemic
AlphaFold has released free, AI-predicted protein complex structures for more than 2,812 human-infecting viruses. Here is what the pandemic preparedness update means for global science.
Editor's picks
See allPentagon Bets $47M That AI Can Out-Evolve the Next Bioweapon
The US Department of War has awarded Flagship Pioneering up to $47 million to build AI platforms that predict viral evolution before outbreaks happen. Here's what the ONTARGET deal means for biosecurity, pandemic readiness and the AI-bio arms race.
The World Just Built an AI Factory for the Next Pandemic
AI Co-Scientists Are Here, and Nature Just Put Them to the Test
This Open-Source AI Just Beat 23 of 26 Radiologists
The AI Biotech With 37,000 Virtual Employees Just Published in Science
AI
See allVirology
See allRecent posts
See allBig Pharma's AI Arms Race: Why Novo Nordisk Just Bet on Claude
Novo Nordisk just added Anthropic's Claude Science to an AI drug discovery stack that already includes OpenAI. Here's what the deal reveals about AI in healthcare.
AI Says It Can Beat the WHO at Picking Flu Vaccines. Can It?
A new protein-language-model study claims to out-predict the WHO's flu vaccine picks, reviving a live dispute over whether AI truly beats expert judgement here.
Tiny AI Models Just Outsmarted the Frontier Giants on Ageing Science
A new Cell study pits 18 leading AI systems against ageing biology data. Small, specialised models beat every frontier system, and the whole toolkit is free to use.
Delphy: Bayesian Phylogenetics at Outbreak Speed
Delphy reformulates Bayesian phylogenetics around explicit mutations and runs in a browser, cutting an H5N1 outbreak analysis from over 21 days to 42 minutes.
Pharma's Locked Structures Just Trained an AI
Five pharmaceutical companies fine-tuned OpenFold3 on 20,167 private protein–ligand structures without pooling the data. Protein–ligand accuracy jumped from 35.6% to 52.1%. Here is what that means for drug discovery, antiviral design and pandemic preparedness.
Why OpenAI, Anthropic and Google DeepMind Just Agreed to Slow AI Down
Anthropic's Dario Amodei asked rivals to slow AI development and let outside evaluators inside frontier labs. OpenAI and Google DeepMind agreed within days. Here's what's actually being tested, bioweapons risk included.
Biology
See allEvolution as Training Data: How Biohub's Open Protein World Model Is Rewiring Drug Discovery
Biohub's open-source ESM models learned the rules of protein biology from evolution alone — and designed working drug binders in days. Here's what the release means, and where it falls short.